EMEA-003048-PIP01-21
Key facts
| Active substance |
Pyridine-3-carboxamide derivative (K-161)
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0467/2021
|
| PIP number |
EMEA-003048-PIP01-21
|
| Pharmaceutical form(s) |
Eye drops, solution
|
| Condition(s) / indication(s) |
Treatment of dry eye disease
|
| Route(s) of administration |
Ocular use
|
| Contact for public enquiries |
Kowa Pharmaceuticals Europe AG
Email: paediatrics@kowapharma.ch |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|